PHARMAPRINT Trademark

Trademark Overview


On Tuesday, October 8, 1996, a trademark application was filed for PHARMAPRINT with the United States Patent and Trademark Office. The USPTO has given the PHARMAPRINT trademark a serial number of 75178758. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, April 21, 2000. This trademark is owned by ABT Global Pharmaceutical Corp.. The PHARMAPRINT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce the symptoms of premenstrual stress (pms), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the resp...

General Information


Serial Number75178758
Word MarkPHARMAPRINT
Filing DateTuesday, October 8, 1996
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateFriday, April 21, 2000
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 28, 1998

Trademark Statements


Goods and Servicespharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce the symptoms of premenstrual stress (pms), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the respiratory and urinary tracts; promote the flow in menstruation and reduce cramping pain; reduce certain types of skin outbreaks (eczema), reduce the pain of migraine headaches and menstrual periods, and are used in the treatment of asthma and arthritis; breakdown of blood clots; reduce nausea by acting on the digestive tract; and of abnormal changes in the light sensing portion of the eye, i.e., retina; reduce stress and damage caused to the liver; are used in the treatment of cancer; and are a general tonic; reduce cramping pain, muscle and joint pain; heart conditions associated with the elderly, mild heart pain brought on by exertion (angina), and mild irregularities of the heart beat; and lower blood pressure; are used in the treatment of degenerative arthritis; reduce distress of the intestinal tract; and improve the clearing of mucus from the lungs; cause sleepiness and treats insomnia; are used in the treatment of ulcers and arthritis; reduce inflammation; and improve the clearing of mucus from the lungs; protect the liver, including against scarring (cirrhosis) and inflammation (hepatitis); are a free radical scavenger and antioxidant; reduce pain and inflammation and improve insomnia and bronchial asthma; are used in the treatment of cancer and diabetes; and in some ways act like an antioxidant; have an effect against cancer; lower blood pressure; help protect a developing fetus against damage from exposure of drugs, chemicals and certain other materials; help the body remove excess fluid through urination; are used in the treatment of asthma; improve rheumatism; and stimulate the growth of hair; promote sleepiness; calm; modify the activity of the body's immune system; and reduce elevated levels of certain fatty substances in the blood; treat cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 31, 1996
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePHARMAPRINT INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92714

Party NamePHARMAPRINT INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92612

Party NameABT Global Pharmaceutical Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92714

Trademark Events


Event DateEvent Description
Friday, August 2, 2002PAPER RECEIVED
Tuesday, April 17, 2001ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 29, 2000DIVISIONAL PROCESSING COMPLETE
Wednesday, April 19, 2000DIVISIONAL REQUEST RECEIVED
Monday, December 6, 1999EXTENSION 2 GRANTED
Tuesday, October 19, 1999EXTENSION 2 FILED
Thursday, June 3, 1999EXTENSION 1 GRANTED
Monday, April 19, 1999EXTENSION 1 FILED
Tuesday, October 20, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 1998PUBLISHED FOR OPPOSITION
Friday, June 26, 1998NOTICE OF PUBLICATION
Tuesday, May 12, 1998APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 19, 1997NON-FINAL ACTION MAILED
Friday, April 11, 1997ASSIGNED TO EXAMINER